When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SGMO - Sangamo Therapeutics: Remaining Bullish Ahead ASH Data In December
Sangamo Therapeutics Inc.
Sangamo Therapeutics is ready to present data from their sickle cell and hemophilia A gene therapy programs at ASH. I believe the data could trigger a reversal by year-end.
I discuss why I believe the ASH data is so important for both the near-term and long-term outlook for the stock.
The recent sell-off has provided me with an opportunity to buy at a discount ahead of the ASH presentations. I reveal my plans for my SGMO position.